inVentiv Health in $1.1 billion sale to private equity firm

Share this article:
InVentiv Health is being acquired by Thomas H. Lee Partners for $1.1 billion.

As MM&M went to press, stockholders were set to vote on the planned sale, announced in May, to Papillon Holdings, Inc., a Thomas H. Lee subsidiary, at a July 21 meeting. Shares in the company had jumped past $25 in anticipation of a sale.

InVentiv Health formed from the 2005 merger of a private agency network, Columbus-based InChord Communications, and Ventiv Health, a Somerset, NJ-based, publicly-held contract sales firm, for $185 million. At that time, the InChord agencies, including GSW Worldwide and Palio Communications, were expected to contribute a quarter of the combined company's revenue. By the end of 2009, it was closer to a third, with the communications division contributing $310 million in revenues.

InVentiv saw its revenues fall from $1.12 billion in 2008 to $1.07 billion in 2009, but the company said that the sour economy and the contracting US pharma industry did not prompt the move.

“There are several reasons we decided to enter into this transaction,” said Marcia Frederick, head of PR at InVentiv. “Going private will enable InVentiv to take a longer-term approach to gr

owth, rather than focusing so intently on quarter-over-quarter performance. It also will allow us to make strategic investments that will help us to continue expanding our offerings to clients. Finally, we selected THL because they understand and support our corporate vision, bring strong strategic insights, and are committed to working with us to achieve long-term growth.”

The company faces an investor lawsuit, filed in Delaware State Court, alleging breaches of fiduciary duty by the board of the company, which the litigants allege sold too cheaply. At press time, the complaint had not yet been certified by a judge, making it unclear whether the case could go forward.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric